Navigation Links
Common gene variants influence risk factor for sudden cardiac death
Date:3/23/2009

A new study has identified several common genetic variants related to a risk factor for sudden cardiac death. The report receiving early online release in the journal Nature Genetics identifies variants in genes, some known and some newly discovered, that influence the QT interval measured on the electrocardiogram (EKG) performed routinely in doctors' offices. These findings could eventually help to prevent sudden cardiac death and arrhythmia by limiting the use of medications that affect QT interval in people with these variants.

The QT interval is the time from the beginning of electrical activation of the heart to the end of electrical relaxation. "It is well established that prolongation of the QT interval in the general population is a potent and heritable risk factor for sudden death," said Christopher Newton-Cheh, MD, MPH, of the Massachusetts General Hospital (MGH) Center for Human Genetic Research and Cardiovascular Research Center (CVRC) and lead author of the Nature Genetics article. "In addition, QT prolongation results from medications leading to drug-induced cardiac arrhythmias and sudden death. This is a cardiotoxic side effect of scores of medications in widespread use and has been a major barrier to the development of novel drugs. From studies of families with congenital long-QT syndrome, we know that rare mutations with strong effects on ion channel function lead to QT prolongation and sudden death. But the common genetic basis for QT prolongation has been very difficult to establish."

To search for QT-associated variants, the investigators formed the QTGEN consortium, assembling more than 13,000 individuals from three studies including the National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, the Rotterdam Study and the Cardiovascular Health Study. All individuals had undergone testing of hundreds of thousands of common gene variations called single-nucleotide polymorp
'/>"/>

Contact: Jennifer Gundersen
jgundersen1@partners.org
617-724-6433
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Catching the common cold virus genome
2. Computer superpower strengthens attempts to combat common diseases
3. Common gene variants increase risk of hypertension, may lead to new therapies
4. New vaccine developed for preventing uncommon cold virus
5. Genetic testing not cost-effective in guiding initial dosing of common blood thinner
6. Common soil mineral degrades the nearly indestructible prion
7. Scientists uncover evolutionary keys to common birth disorders
8. Mayo Clinic: Brain disorder suggests common mechanism may underlie many neurodegenerative diseases
9. Common food additive found to increase risk and speed spread of lung cancer
10. Hairspray is linked to common genital birth defect, says study
11. GUMC researchers hone in on new strategy to treat common infection

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...Those extra helpings of gravy and dessert at the h...line than previously thought. According to a new r...ASEB Journal ( http://www.fasebj.org ), a diet th...n genes that ultimately cause our bodies to store ...a double-whammy as the already difficult task of c...
(Date:11/30/2009)... This release is available in German . , Th...laborative Research Centres as of 1 January 2010. ...ants Committee in Bonn. The new centres will initi...million. In addition, 20 percent overhead funding ...project. The centres, research topics range from m...
(Date:11/30/2009)...HOBOKEN, N.J. - The inaugural Global Conference o...r 3-4, 2009, in Washington, DC, focuses on the con...rises of critical importance to society. , T...of research activity around targeted complex syste...s year,s topic includes Critical Infrastructure Sy...
Breaking Biology News(10 mins):Happy holidays from the groaning board; Western diets turn on fat genes 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 1Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 2Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 3Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 4Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 5Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 6Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 7Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 8Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 9Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 10Reportlinker Adds North American Market for Third Party Payroll Payment and Healthcare Transaction Processing 3rd Edition The Report 58030 11Upcoming trends in hematological malignancies 58028 1IOM report released on species jumping diseases 58026 1IOM report released on species jumping diseases 58026 2IOM report released on species jumping diseases 58026 3
...just the climate that is struggling with what huma...eling the pressure as well, according to Professor...Takes a Genome: How a Clash Between Our Genes and ...from UQ,s School of Biological Sciences, suggests ...cancer and Alzheimer,s are due to human genes bein...
...f leading UK scientists and social scientists led ...y of Edinburgh, calls for joined-up thinking on th... gold. The world is waking up to the potential of ...o carbon sinks, there is growing talk of plants re...my. , But such fame comes at a price. , Recent...
...a from the satellite-based MIPAS and GOME-2 instru... important bromine species in the atmosphere. Thes...understand sources of ozone-depleting species and ...istry. , Despite the detection of bromine monoxid...ne nitrate (BrONO2) was first observed in 2008 whe...
Other Biology News:'It takes a genome: How a clash between our genes and modern life is making us sick' 2Plants are political hot potatoes 2European satellites provide new insight into ozone-depleting species 2
(Date:11/30/2009)...v. 30 Cell Therapeutics,... that its new class of platinum-based anti-tumor c...ronger anti-tumor potency and activity compared to...ell as the ability to overcome cisplatin-resistanc...d in a paper titled "Novel Bis-platinum Complexes ...
(Date:11/30/2009)...ON, November 30 ApaTech, the rapid...e,s fastest growing,Biotech/Pharmaceutical/Medical... Technology Fast 500 for EMEA (Europe, Middle East...sed on a companies, five-year revenue growth,for ...his period. This,achievement places ApaTech 9th ov...
(Date:11/28/2009)... Vanuatu National Advisory Committee on Climate Ch...tion (SNC) Project in collaboration with the Vanua... New Zealand have generated preliminary climate ch... background for the country’s SNC reporting ...ate Change (UNFCCC). , P...
(Date:11/27/2009)...echanised blue dye test alternative is helping b...rance one step closer for pharma-companies. It is ...ine developed by Sepha for use with blister pack...al and global pharma-companies such as Sanofi-Aven...and productivity improvements on the packaging lin...
Breaking Biology Technology:New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3
...4 Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), ...g,developing and commercializing proprietary produ...setting, announced today that the company,s,Presid...mpany,s corporate,overview at the following invest...cialty Pharmaceuticals Conference at the South...
...nues - a record $35.5 million vs. $24.7 million in...43.4%, Q2 2008 Diluted Net Income per Share - $0... increase of 62.5% Q2 2008 Operating Inco...New Bookings of $49.0 million vs. $34.5 million in...gy,Inc. (eRT), (Nasdaq: ERES ), a leading provide...
...., Aug. 4 Telik, Inc.,(Nasdaq: TELK ) announced ...ebcast will be held on Monday, August 11, 2008 at ...llowing the release earlier that day of the,compan... June 30, 2008., The conference call will be acce...m or by telephone at 800-553-5260 or 612-332-0720...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008 2eResearchTechnology Reports Second Quarter 2008 Results 2eResearchTechnology Reports Second Quarter 2008 Results 3eResearchTechnology Reports Second Quarter 2008 Results 4eResearchTechnology Reports Second Quarter 2008 Results 5eResearchTechnology Reports Second Quarter 2008 Results 6eResearchTechnology Reports Second Quarter 2008 Results 7eResearchTechnology Reports Second Quarter 2008 Results 8eResearchTechnology Reports Second Quarter 2008 Results 9
Rabbit anti-Alpha-4 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Amino Acid Mixture Minus Cysteine from Promega
Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Unconjugated from R&D Systems
CometSlide from R&D Systems
Biology Products: